- Home
- ORMP vs BTCS Comparison
ORMP vs BTCS Comparison
Compare ORMP & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORMP | BTCS |
|---|---|---|
| Founded | 2002 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 120.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | BTCS |
|---|---|---|
| Price | $3.45 | $2.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 324.8K | ★ 749.7K |
| Earning Date | 11-13-2025 | 03-19-2026 |
| Dividend Yield | ★ 7.18% | 1.82% |
| EPS Growth | ★ 838.25 | 644.42 |
| EPS | 1.03 | ★ 1.76 |
| Revenue | $2,000,000.00 | ★ $11,724,983.00 |
| Revenue This Year | N/A | $248.05 |
| Revenue Next Year | N/A | $41.01 |
| P/E Ratio | $3.39 | ★ $1.55 |
| Revenue Growth | N/A | ★ 464.28 |
| 52 Week Low | $1.82 | $1.25 |
| 52 Week High | $3.71 | $8.49 |
Technical Indicators
Market Signals| Indicator | ORMP | BTCS |
|---|---|---|
| Relative Strength Index (RSI) | 57.20 | 41.70 |
| Support Level | $3.33 | $2.53 |
| Resistance Level | $3.60 | $2.74 |
| Average True Range (ATR) | 0.22 | 0.15 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 43.48 | 19.85 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About BTCS BTCS Inc.
BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.